FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Preclinical Psoriasis Data Presented at SID Annual Meeting On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation ...

All poster presentations will take place in Poster Hall I2 ... of mHTT protein in HD patient-derived fibroblasts and clinically relevant BACHD murine model following intrastriatal injections with LETI ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

according to a poster presentation at the Association for Research in Vision and Ophthalmology meeting. Andy Ng and colleagues created an AI model that combined image and parameter data to ...

In the 'immune warm' CT26 mouse tumor model, vaccine abrogates or slows tumor growth – durable protection against rechallenge supports efficient induction of immune memory; vaccine + αPD1 ...

("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in ...

At Google I/O 2025, Google has announced Imagen 4, it's latest image generator model that better renders droplets, fur, and ...

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease ...